Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosis

Cancer biomarkers are the backbone for the implementation of individualized approaches to bladder cancer (BCa). Hyaluronic acid (HA) and all 7 members of the HA family, that is, HA synthases (HA1, HA2, HA3), HYAL‐1 hyaluronidase, and HA receptors (CD44s, CD44v, and RHAMM), function in tumor growth and progression. However, the diagnostic and prognostic potential of these 7 HA family members has not been compared simultaneously in any cancer. We evaluated the diagnostic and prognostic potential of HA family members in BCa.

[1]  A. Belldegrun,et al.  Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. , 2010, The Journal of urology.

[2]  V. Lokeshwar,et al.  Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. , 2010, Cancer research.

[3]  M. Swellam,et al.  Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer. , 2010, The Journal of urology.

[4]  S. Lele,et al.  Udp‐glucose dehydrogenase as a novel field‐specific candidate biomarker of prostate cancer , 2010, International journal of cancer.

[5]  M. Jordá,et al.  HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer. , 2010, European urology.

[6]  Valsamo Anagnostou,et al.  Antibody validation. , 2010, BioTechniques.

[7]  M. Jordá,et al.  Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence. , 2009, The Journal of urology.

[8]  Christian G Elowsky,et al.  Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. , 2009, The American journal of pathology.

[9]  M. Swellam,et al.  Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer. , 2008, Clinical biochemistry.

[10]  V. Kosma,et al.  Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. , 2008, Seminars in cancer biology.

[11]  M. Simpson,et al.  Hyaluronan and hyaluronidase in genitourinary tumors. , 2008, Frontiers in bioscience : a journal and virtual library.

[12]  E. Turley,et al.  Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? , 2008, Journal of Cell Science.

[13]  M. Kramer,et al.  Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. , 2008, Cancer research.

[14]  P. Heldin,et al.  Importance of Hyaluronan-CD44 Interactions in Inflammation and Tumorigenesis , 2008, Connective tissue research.

[15]  M. Simpson,et al.  Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis* , 2007, Journal of Biological Chemistry.

[16]  Lynette M. Smith,et al.  Quantitative Fluorescence Imaging Analysis for Cancer Biomarker Discovery: Application to β-Catenin in Archived Prostate Specimens , 2007, Cancer Epidemiology Biomarkers & Prevention.

[17]  P. Heldin,et al.  Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells , 2007, International journal of cancer.

[18]  Brian L. Cohen,et al.  HAS1 expression in bladder cancer and its relation to urinary HA test , 2007, International journal of cancer.

[19]  Lynette M. Smith,et al.  Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens. , 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  S. Ghatak,et al.  Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells* , 2006, Journal of Biological Chemistry.

[21]  A. Aboughalia,et al.  Elevation of hyaluronidase-1 and soluble intercellular adhesion molecule-1 helps select bladder cancer patients at risk of invasion. , 2006, Archives of medical research.

[22]  M. Srougi,et al.  Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder. , 2006, European urology.

[23]  E. Messing,et al.  Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. , 2005, Urology.

[24]  V. Lokeshwar,et al.  HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. , 2005, Cancer research.

[25]  V. Lokeshwar,et al.  HYAL 1 Hyaluronidase : A Molecular Determinant of Bladder Tumor Growth and Invasion , 2005 .

[26]  M. Soloway,et al.  Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL‐1), CD44v6 and microvessel density for prostate cancer , 2004, International journal of cancer.

[27]  U. Michl,et al.  Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison. , 2004, European urology.

[28]  H. Huland,et al.  A side by side comparison of cytology and biomarkers for bladder cancer detection. , 2004, The Journal of urology.

[29]  F. Badary,et al.  Expression of CD44 protein in bilharzial and non‐bilharzial bladder cancers , 2004, BJU international.

[30]  H. Miyake,et al.  Over expression of CD44V8-10 in human bladder cancer cells decreases their interaction with hyaluronic acid and potentiates their malignant progression. , 2004, The Journal of urology.

[31]  U. Nseyo,et al.  CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors , 2004, International Urology and Nephrology.

[32]  Xiao-yan Chen,et al.  Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder. , 2003, Oncology reports.

[33]  K. Kimata,et al.  Mammalian Hyaluronan Synthases , 2002, IUBMB life.

[34]  S. Hautmann,et al.  Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid–hyaluronidase and BTA‐Stat tests , 2002, Cancer.

[35]  J. Rao,et al.  Protein expression analysis using quantitative fluorescence image analysis on tissue microarray slides. , 2002, BioTechniques.

[36]  H. Miyake,et al.  Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer. , 2002, The Journal of urology.

[37]  C. Öbek,et al.  Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. , 2000, The Journal of urology.

[38]  Arakawa,et al.  Utility of Competitive Reverse Transcription-Polymerase Chain Reaction Analysis of Specific CD44 Variant RNA for Detecting Upper Urinary Tract Transitional-Cell Carcinoma. , 1999, Molecular urology.

[39]  G. P. HemstreetIII.  Genetic instability and tumor cell variation , 1998 .

[40]  Robert E. Hurst,et al.  Instrumentation, Accuracy, and Quality Control Issues in Development of Quantitative Fluorescence-Image Analysis (QFIA) , 1998 .

[41]  A. Olsen,et al.  Chromosomal localization of the human and mouse hyaluronan synthase genes. , 1997, Genomics.